Read more

An expert panel of the global health body is meeting on Tuesday, October 5, to decide on Bharat Biotech’s Covid-19 vaccine Covaxin getting the Emergency Use Listing (EUL) authorization, according to documents detailing the committee’s agenda for the meeting and the assessment status of pending applications for vaccine candidates. Top health experts say the approval of the vaccine shouldn’t be delayed after reviewing the data this month. India’s indigenously-developed vaccine, Covaxin against Covid-19, has so far not received the much-coveted emergency use approval from the World Health Organization (WHO) but is likely to do so soon.

Till now, the World Health Organization has only included six Covid-19 vaccine candidates in its EUL. These are the Pfizer-BioNTech vaccine, the Johnson and Johnson (J&J) vaccine, the Oxford-AstraZeneca vaccine which is being manufactured as Covishieldby the Serum Institute of India, the Moderna jab and the Sinopharm and Sinovac vaccines.

The Supreme Court Monday said no state shall deny the ex-gratia compensation of Rs 50,000 to the next of kin of the deceased due to Covid-19 solely on the ground that death certificate does not mention the virus as the cause of death. The ex-gratia compensation is to be disbursed within 30 days from the date of submitting the application to the concerned District Disaster Management Authority/District Administration along with the proof of the death of the deceased due to Covid-19 and the cause of death being certified as “Died due to Covid-19”, the apex court said.

Read all the Latest News, Breaking News and Coronavirus News here. Follow us on Facebook, Twitter and Telegram.